t e C h n I C a l r e p O r t S There are many transgenic GFP reporter lines that allow the visualization of specific populations of cells. Using such lines for functional studies requires a method that transforms GFP into a molecule that enables genetic manipulation. We developed a method that exploits GFP for gene manipulation, Cre recombinase dependent on GFP (CRE-DOG), a split component system that uses GFP and its derivatives to directly induce Cre/loxP recombination. Using plasmid electroporation and AAV viral vectors, we delivered CRE-DOG to multiple GFP mouse lines, which led to effective recombination selectively in GFP-labeled cells. Furthermore, CRE-DOG enabled optogenetic control of these neurons. Beyond providing a new set of tools for manipulation of gene expression selectively in GFP + cells, we found that GFP can be used to reconstitute the activity of a protein not known to have a modular structure, suggesting that this strategy might be applicable to a wide range of proteins.
A challenge to the understanding of brain function is the ability to monitor and/or manipulate the activity of the many different cell types comprising the nervous system. To label specific cell types, many transgenic reporter lines using GFP 1,2 as a marker of gene expression 3 have been generated for various model organisms. Notably, over 1,000 transgenic GFP mouse lines have been characterized for labeling specific cell populations in the CNS (http://gensat.org/index. html) [4] [5] [6] . Until recently, GFP lines have only been used for labeling purposes. However, studies probing cellular function often require genetic manipulations, such as using mouse lines expressing sitespecific DNA recombinases in specific cell types to drive the expression or deletion of particular genes. Compared with GFP reporter lines, the availability of mouse lines expressing the widely used Cre recombinase in specific cell types is more limited, and Cre expression patterns have not been as extensively characterized (http://gensat.org/ index.html and http://brain-map.org/). Manipulation of GFP-labeled cell types previously required the generation of new mouse lines, for example, using the same cis-regulatory sequences that drove GFP in specific cell types to drive Cre expression in the same cell types. For more complex model organisms, such as the mouse, such an approach is costly and time-consuming. Furthermore, the expression pattern of Cre in these lines could differ from that of the equivalent GFP reporter line, potentially as a result of a combination of high sensitivity of Cre and/or position effects exerted by neighboring genomic sequences.
Recently, we developed GFP-dependent transcription factors (T-DDOGs) that enable retrofitting of transgenic GFP lines for functional manipulation studies 7 . In this system, GFP acts as a scaffold, bringing together modular transcription domains to assemble a hybrid transcription factor for activation of a target gene of interest. GFP recognition is mediated by pairs of GFP-binding proteins (GBPs), which were derived from the antigen recognition portion of camelid antibodies 8, 9 . These 'nanobodies' are easily expressed in living cells and can be used as fusion proteins [7] [8] [9] [10] . T-DDOGs opened the door for quick genetic manipulation of GFP-labeled cells via DNA electroporation, bypassing the need to generate transgenic Cre lines for cell-specific gene manipulations in certain cases 7 .
Several reasons motivate the continued development of new GFP-dependent systems. First, unlike transcription factors 11, 12 , many proteins such as enzymes are not composed of simple modular structures. It is unclear whether GFP can be used to directly control the activity of such non-modular proteins. Second, many genetic tools depend on the action of Cre recombinase. Although T-DDOG can induce Cre expression, this effect requires the action of three genetically encodable components. Although electroporation can efficiently deliver multiple plasmids encoding T-DOGG to single cells, this approach is restricted to certain tissues and developmental time points. In contrast, the popular recombinant adeno-associated viral (rAAV) vectors can efficiently deliver multiple transgenes to single cells, across diverse tissues and over different developmental and/or mature stages. rAAVs encoding the recombinase-dependent flipexcision (FLEX) switch further enable convenient and selective expression of transgenes in specific cell types when injected into transgenic Cre and/or Flp lines [13] [14] [15] . The integration of GFP-inducible systems with FLEX responder genes in a rAAV delivery scheme would t e C h n I C a l r e p O r t S provide a simple protocol for rapid manipulation of many types of genes selectively in GFP-labeled cell types. Furthermore, such a method would increase the number of specific cell types that could be manipulated with intersectional approaches, as transgenic animals with a combination of GFP and Flp in specific cell types could activate transgenes that are Cre and Flp dependent 14, 16 .
We used GFP to control the activity of Cre, in the form of split Cre-GBP fusion proteins that together make up CRE-DOG. The GBP-Split Cre fusion proteins assembled as a complex on the GFP scaffold, initiating Cre recombination (Fig. 1a) . This system requires only two components for direct activation of Cre recombination (Supplementary Fig. 1 ). We generated rAAV reagents that enabled delivery of CRE-DOG to diverse tissues and brain regions that cannot be electroporated, for rapid and tight GFP-regulated Cre-dependent transgene expression across GFP reporter lines and cell types. To demonstrate the utility of this approach, we showed that CRE-DOG could be used for optogenetic manipulation of GFP-expressing cells in the nervous system.
RESULTS
CRE-DOG refers to the combined action of two chimeric proteins bearing complementary split Cre fragments 17 , each fused to a different GBP. We tested the GBP1+GBP6 and GBP2+GBP7 combinations, as they have been used to assemble a hybrid transcription factor on the GFP scaffold in living cells 7 . Using a CAG-loxP-Neo-loxP-luc2 (CALNL-luc2) construct (or floxed luciferase reporter), we screened pairs of the GBP-split Cre fusion proteins for GFP-dependent activity. Almost all of the GBP-split Cre pairs had either low GFP-induced recombination activity or high background activity (data not shown). We considered whether it would be possible to increase efficiency by generating a full-length Cre recombinase via protein splicing 18 . To this end, we inserted the artificially split S. cerevisiae vacuolar ATPase (VMA1) intein elements 19, 20 into the GBP-split Cre constructs and conducted additional reporter screens. None of the constructs based on the GBP1+GBP6 pair yielded high-efficiency recombination. However, a subset of constructs based on the GBP2+GBP7 combination resulted in the desired GFP-dependent Cre activity with reasonably low background activity. The most desirable pair of fusion constructs showed strong GFP-dependent recombination activity in vitro and in vivo and was named CRE-DOG OG (Supplementary Fig. 2) . CRE-DOG OG refers to the combined action of two fusion protein components, N-CreintG and C-CreintG. In contrast with the T-DDOG system, which carries the caveat of being potentially toxic to cells as a consequence of the squelching phenomenon caused by transcription activation domains 21 , CRE-DOG OG did not induce any noticeable abnormality in retinal cells.
Although intein elements were intended to create a Cre protein via protein splicing, we failed to find evidence that supported this mechanism in several tests ( Supplementary  Fig. 3 ). To promote protein splicing, the splitintein of VMA1 requires a cysteine residue at the boundary between each split-intein and its respective fusion partner 22 . Double alanine and double serine substitutions at the cysteine positions were expected to disrupt protein splicing 22 , but had little adverse effect on the GFP specificity or efficiency of CRE-DOG OG (Supplementary Fig. 3a) . Second, each split VMA element promoted GFP specificity even in the absence of its protein splicing partner ( Supplementary Fig. 3b ). Third, under conditions in which GFP could induce the activity of a FLAG-tagged CRE-DOG OG variant, we failed to detect the appearance of spliced, full-length Cre in the presence of GFP ( Supplementary Fig. 3c,d) . Nonetheless, as these combined fusion proteins provided a more active GFP-dependent Cre, we continued to optimize these constructs.
Although CRE-DOG OG yielded GFP-dependent recombination in vitro and in vivo, background activity in the absence of GFP did accumulate noticeably over time in vitro (data not shown). Thus, we conducted additional screens to further optimize CRE-DOG OG activity. We found that the 184 amino acid (aa) N-terminal portion of VMA (N-VMA) could be further truncated without adversely affecting CRE-DOG activity. Serial residue deletion and insertion scans along N-VMA led to the isolation of a 43-aa truncated element that promoted both enhanced GFP-dependent recombination and reduced GFP-independent activity when compared with CRE-DOG OG (Supplementary Figs. 4 and 5, and Supplementary Table 1 ). This truncated fusion protein, hereafter named N-CretrcintG, was combined with C-CreintG to give the optimized CRE-DOG (CRE-DOG OPT ) ( Fig. 1b) . CRE-DOG OPT activity depended on all of the components of the system and was specific for GFP and its derivatives ( Fig. 1c,d) . Furthermore, CRE-DOG OPT activity was dependent on GFP dosage in a manner similar to that observed for T-DDOGs 7 (Fig. 1e) .
We next tested whether CRE-DOG could retrofit existing transgenic GFP reporter lines for cell type-specific manipulations. The Tg(CRX-GFP) line expresses GFP strongly in photoreceptors and weakly in inner nuclear layer (INL) cells 23 . Tg(CRX-GFP) retinas electroporated with CRE-DOG OPT and CALNL-DsRed plasmids showed strong DsRed labeling of photoreceptors and occasional labeling of INL cells, whereas electroporated retinas that were GFP-negative showed little to no DsRed expression ( Fig. 2a,b and Supplementary  Fig. 6a-c) . In addition, 100 ± 0% (hereafter, data are presented as mean ± s.d., unless indicated otherwise) of DsRed cells labeled in the outer nuclear layer (ONL) were GFP + (Supplementary Fig. 6g ). CRE-DOG OPT induced DsRed expression in 76 ± 4% of electroporated npg t e C h n I C a l r e p O r t S cells in the ONL (Supplementary Fig. 6a ). This is an estimate of CRE-DOG OPT efficiency in vivo, as all electroporated cells in the ONL were GFP + . The value is likely an underestimate of efficiency, as it has not been corrected for the percentage of cells that were co-electroporated with all constructs. Given that a considerable retinal diversity lies in the bipolar cell class, we tested whether CRE-DOG OPT would be effective in this cell class. We used a bipolar-selective promoter (ChAG) to drive strong expression of CRE-DOG OPT components in various bipolar cell types of the Tg(PROX1-GFP) line, and assayed Cre activity with a ChAG-loxP-TagBFP-loxP-mCherry reporter (ChAG-LtBFPL-mCherry). In contrast with Tg(CRX-GFP), electroporated Tg(PROX1-GFP) retinas showed strong mCherry labeling of bipolar cells, as well as sparse labeling of photoreceptors, and rare labeling of Müller glia and amacrine cells ( Fig. 2c) . Although only 83 ± 10% of mCherry + cells were GFP + (Supplementary Fig. 6g ), analysis of electroporated GFP-negative retinas revealed that the system was absolutely GFP dependent ( Fig. 2c and Supplementary Fig. 6d,e ). Thus, developmental expression of Tg(PROX1-GFP) in progenitor cells giving rise to multiple cell classes or weak/transient GFP expression may contribute to the labeling pattern. These results establish the utility of CRE-DOG for genetic manipulation of specific cell types in transgenic GFP animals.
rAAVs are widely used vectors for delivering transgenes to the mammalian nervous system given their high infectivity of postmitotic neurons and low toxicity 24 . The ability to deliver rAAV-encoded CRE-DOG OPT along with rAAV carrying the tight Cre-responsive FLEX switch 13 in a single injection mixture would provide a fast and versatile approach for manipulating genes in GFP-labeled cell types across wide areas of the nervous system and across a broad age window. Indeed, rAAV-encoding CRE-DOG OPT could be used to turn on rAAV-FLEX-tdTomato (tdT) in a GFP-dependent manner in vivo (Supplementary Fig. 7a ). To test this approach in transgenic GFP lines, we co-injected rAAV-CRE-DOG OPT and rAAV-FLEX-tdT into retinas of Tg(TRHR-GFP) 25 and Tg(CDH3-GFP) 26 lines, both of which express GFP in specific retinal ganglion cell (RGC) subtypes. Functional studies of RGCs have been hampered by the scarcity of Cre driver lines that are selectively active in the same RGC subtypes seen in multiple GFP reporter lines. Single injection of the aforementioned rAAV mixture into GFP-negative retinas resulted in no detectable tdT expression in Cre-immunopositive cells of the ganglion cell layer (GCL) (0 tdT + cells in 140 anti-Cre + cells, sampled across three retinas; Supplementary Fig. 7b ). In contrast, we found highly selective tdT expression in GFP + RGCs, with 89 ± 7% of tdT + cells being TRHR-GFP + (207 of 243 tdT + cells, 5 retinas) and 85% of tdT + cells being CDH3-GFP + (11 of 13 tdT + cells, 2 retinas); npg t e C h n I C a l r e p O r t S and data not shown for Tg(CDH3-GFP)). The sparser number, as well as non-uniform spatial distribution of CDH3-GFP + RGCs, may contribute to the low number of cells labeled by tdT 26, 27 . Notably, strong tdT expression enabled tracing of labeled RGC projections into various brain targets; the resultant patterns were consistent with the identity of GFP + RGCs previously characterized for Tg(TRHR-GFP) ( Fig. 3c,d) 25 . Taking together the rAAV and electroporation results, we found that one can use CRE-DOG OPT to selectively target GFP cells residing in all three major cellular layers of a neural tissue, the retina.
To evaluate whether CRE-DOG is useful outside of the retina, we co-injected rAAV-CRE-DOG OPT and rAAV-FLEX-tdT into additional neural tissues. We targeted GFP cells of the spinal cord in the Tg(CBLN2-GFP) line 4 , which expresses GFP in a subset of interneurons in the dorsal horn (unpublished data, V.E.A., and Fig. 4a ). Although rAAV infection of wild-type spinal cords did not result in detectable tdT expression (0 tdT + of 108 anti-Cre + cells, sampled from two spinal cords), infection of Tg(CBLN2-GFP) spinal cords led to the appearance of tdT + cells, some of which expressed tdT at levels strong enough for visualization of fine processes (Fig. 4b,c ). We found that 75% of tdT + cells were GFP + (n = 105 tdT + cells, sampled from two spinal cords). Thus, the labeling pattern may include cells that had transient and/or low levels of GFP, below the detection threshold. To estimate the efficiency of rAAV-CRE-DOG OPT gene manipulation protocol in the spinal cord, we quantified the number of tdT + cells among the GFP + cells that also expressed split-Cre fragments, as detected by a polyclonal Cre antibody. Using this approach, we estimated the efficiency to be 51% (n = 37 Cre + , GFP + cells, sampled from two spinal cords). npg t e C h n I C a l r e p O r t S
We also tested for CRE-DOG OPT activity in the brain. The Tg(GAD67-GFP) line expresses GFP in GABAergic cell types in multiple brain regions 28 . We injected the rAAV mixture encoding CRE-DOG OPT and FLEX-tdT into the motor cortex as well as into the cerebellum of Tg(GAD67-GFP) animals (Figs. 5 and 6, and Supplementary Table 2 ). Cortical infection resulted in GFPdependent induction of tdT expression throughout all cortical layers of Tg(GAD67-GFP) brains ( Fig. 5b-d) . A high percentage of tdT + cells was GFP + , at 98 ± 2% (Fig. 5b) . In addition, 78 ± 10% of GFP + and anti-Cre + cells were also tdT + , providing an estimate of efficiency of the rAAV-CRE-DOG OPT injection protocol in the brain (Fig. 5b) . Notably, despite efficient infection of cortical pyramidal neurons, as evidenced by Cre immunostaining, no pyramidal neurons, and rarely any other cell type, were tdT + in GFP-negative mice (8 tdT + cells in 2,560 anti-Cre + cells, ten sections, two GFP-negative brains; Fig. 5c,d and Supplementary Table 2) . Injection of the rAAV-CRE-DOG OPT and FLEXT-tdT mixture into Tg(GAD67-GFP) cerebella resulted in strong GFP-dependent labeling of multiple GABAergic cerebellar cell types, including Purkinje cells (PCs), molecular layer interneurons (MLIs) and granule layer interneurons (GLIs), as confirmed by morphology and immunostaining for cell type markers ( Fig. 6, Supplementary Figs. 8 and 9, and Supplementary Table 2 ). Anti-Cre staining revealed that there was little to no CRE-DOG OPT activity in GFP-negative cerebella infected with the rAAV mixture ( Fig. 6c,d, Supplementary Figs. 8 and 9e-g, and Supplementary  Table 2 ). In infected Tg(GAD-GFP) cerebella, we found that 96 ± 2% of tdT + cells were GFP + and, in areas of dense infection, 42 ± 10% of all GFP + cells were tdT + (Fig. 6e) . To more accurately evaluate the efficiency of the CRE-DOG OPT system, we quantified the percentage of tdT + cells that were both anti-Cre + and GFP + , which was 55 ± 26% and ranged between 44-67% depending on cell type ( Fig. 6d and  Supplementary Table 2) .
To evaluate the utility of CRE-DOG OPT for functional studies, we co-infected Tg(GAD67-GFP) with rAAV-CRE-DOG OPT and rAAV-FLEX-ChR2-tdT to manipulate GFP + cells optogenetically (Fig. 7a-c) . We were able to directly trigger light-evoked action potentials and photocurrents in ChR2-tdT-labeled PCs (n = 9) and MLIs (n = 6) ( Fig. 7d,e) . We also were able to optogenetically inhibit spontaneous activity in ChR2-tdT-negative PCs that received GABAergic synaptic input from ChR2-tdT + MLIs (n = 4; Fig. 7f ). GFP + PCs in uninfected areas, as well as PCs in infected areas of GFP-negative littermates, did not show any light-induced photocurrents or lighttriggered synaptic currents (n = 9 PCs for GFP-negative animal, n = 8 PCs in uninfected area; Fig. 7g ). Finally, infected PCs and MLIs did not differ from uninfected cells in intrinsic electrical properties, as assessed by membrane resistance and spontaneous action potential frequency (P = 0.92 and 0.73, respectively, one-way ANOVA for PCs, and P = 0.87 and P = 0.81, respectively, t test, for MLIs; Fig. 7h,i) . Together, these results demonstrate the utility of CRE-DOG for cell-specific manipulation of neural circuit activity in the brain.
DISCUSSION
We developed a high signal-to-noise system, CRE-DOG OPT , that provides a reliable and rapid means of genetically manipulating GFP-expressing cells in the many GFP lines available for life science research. We demonstrated the repurposing of GFP reporter lines for cell-specific gene manipulation via electroporation and/or viral infection. Given the widespread use of rAAVs among neuroscientists, rAAV-encoded CRE-DOG OPT should immediately be useful for many neuroscience applications. rAAV allows delivery over a broader time window and into more tissues than electroporation, the method originally used to deliver T-DDOG. It should be straightforward to apply rAAV-encoded CRE-DOG OPT in a single injection mixture with rAAV-encoded Cre-dependent transgenes or into transgenic GFP animals with Cre-responsive alleles. Further refinement in cell targeting should be possible by intersecting GFP-dependent CRE-DOG OPT activity with other recombinases 14, 16 .
The CRE-DOG OPT -encoding plasmids that we developed also will be immediately useful for targeting GFP cells for gene manipulation npg t e C h n I C a l r e p O r t S via electroporation. The electroporation approach holds an advantage over rAAV delivery in that it is not limited by virus packaging size. This can be exploited in several ways, including the delivery of larger Cre-dependent transgenes and/or larger cis-regulatory elements controlling expression patterns of CRE-DOG OPT and/or Cre-dependent transgenes. We tested CRE-DOG OPT in multiple neural tissues in vivo and found that its activity was highly dependent on GFP expression. Notably, the engineered split Cre components retained the ability to induce recombination of responder cassettes in the popular floxed and FLEXed configurations. In multiple tests, CRE-DOG OPT was capable of inducing strong fluorescent reporter protein expression, allowing for visualization of fine neuronal processes for morphological and axonal tracing analysis either with unstained or immunostained tissues (Figs. 2-7 and Supplementary Figs. 7 and 9) . Optogenetic control of specific cell types is a powerful means of dissecting the function of cells in neural circuits 29 . We found that CRE-DOG OPT could convert GFP expression into ChR2 expression for cell type-specific and temporally precise manipulation of neural activity (Fig. 7) . Beyond light-activated ion channels, many other genetically encodable tools have been developed to uncover the anatomical and physiological features of neurons [29] [30] [31] [32] [33] . We anticipate that CRE-DOG OPT could enable activation of any one, or a combination, of these readily available tools in any cell type labeled with GFP.
As with any exogenous construct, the efficiency of CRE-DOG OPT depends on the effectiveness of gene delivery. We found CRE-DOG OPT to be active in ~44-78% of cells receiving electroporated plasmids or virally delivered CRE-DOG OPT components in vivo. These numbers are likely underestimates of the true efficiency, as we could not completely focus our analysis on cells that received the complete set of CRE-DOG OPT components. For example, rAAV-infected cells with only one Cre-fusion protein, or cells with both CRE-DOG OPT components, but not FLEX-tdT, would be included in the population of tdT-negative cells. To increase efficiency, it may be beneficial to encode both CRE-DOG OPT components in a single plasmid or rAAV vector, perhaps by linking the two components in a bicistronic cassette. In addition, transgenic lines expressing the two components in a bicistronic cassette would provide activation in a large number of GFP-labeled cells through the use of genetic crosses. Another consideration when using rAAV is the serotype and the promoter used to drive each CRE-DOG OPT component, as different serotypes and promoters may promote differential expression patterns. Such differences are not necessarily a problem. Instead, they may be exploited for intersectional targeting of CRE-DOG OPT activity for precise cell-specific manipulations 16 . For example, two different promoters may be used to express each of the CRE-DOG OPT components, resulting in Cre activity in a subset of GFP-expressing cells. Alternatively, it may be possible to intersect the spatial pattern of CRE-DOG OPT activity, as dictated by GFP expression, with the expression pattern of other site-specific recombinases and/or transcription factors using dual or multiple input-responsive cassettes 14, 16, 34 .
Both CRE-DOG OPT and T-DDOG may now be used for manipulation of GFP-expressing cells. Several considerations influence the choice npg t e C h n I C a l r e p O r t S of one versus the other. First, overexpression of transcription activation domains may cause undesirable side effects. We found this to be the case for T-DDOG variants using particularly potent activation domains, and overcame the issue by changing the activation domain 7 . Unlike transcription factors, Cre recombinase does not depend on interactions with endogenous cellular machinery and may be expected to induce fewer complications. Indeed, we did not detect any abnormalities in cells overexpressing CRE-DOG OPT . This is supported by physiology experiments in ChR2-expressing cerebellar cells that failed to detect any deleterious effects (Fig. 7) . However, we did encounter cytotoxicity when delivering the components to the cerebellum via serotype 8 capsid, but not serotype 1 capsid (data not shown). This is therefore a serotype-specific issue and not related to CRE-DOG OPT expression. Serotype-specific cytotoxicity has been reported previously and is important to consider when designing experiments 35 . Nevertheless, high levels of native Cre were reported to be toxic in some settings 36 . Second, T-DDOG may be preferred when temporal control is desired, as T-DDOG can be modified to respond to drug application. It is also possible to modify CRE-DOG to confer drug inducibility by using domains such as ERT2 or destabilizing domains 37 . However, this would only enable temporal control at the onset of expression, as Cre-mediated recombination is essentially irreversible. CRE-DOG OPT , as with T-DDOG, is sensitive to high GFP levels in that GFP in excess of the split components can titrate out each component, thereby reducing activity. Nonetheless, empirically, we found Cre-dependent recombination to be fairly efficient, even in lines with strong levels of GFP expression (Figs. 2, 5 and 6) . Also, CRE-DOG OPT was able to detect low GFP levels, as demonstrated by our findings with the relatively weakly GFP-expressing RGC lines, which require GFP immunostaining to reveal neuronal processes (Fig. 3) . In fact, we failed to detect GFP in some cells with evidence of recombinase activity, presumably because activity was triggered by GFP expression below the threshold of detection or from transient GFP expression ( Figs. 2 and 4) . This does point out that the proper control for CRE-DOG OPT is a GFP-negative animal; we detected almost no CRE-DOG OPT activity in GFP-negative tissues.
The irreversibility of Cre recombination can be exploited to trigger stable expression of a transgene, but may also lead to accumulation of background, even if there is only low GFP-independent recombinase activity. We did not find background activity to be an issue for our incubation period of 2-4 weeks. However, beyond this incubation period, we did observe increased background in rAAV-CRE-DOG OPTinjected GFP-negative animals (data not shown). The accumulation of background may be reduced by optimizing plasmid dose or viral titer, and/or by using tightly drug-regulated CRE-DOG OPT variants that await development. Another contributor to variable background activity may be the differential sensitivity of Cre-responsive gene cassettes; in our experience, FLEX constructs showed less background recombination than loxP-STOP-loxP alleles.
Although split intein elements were found to promote GFPspecificity of CRE-DOG, protein splicing did not seem to be involved. It is unclear why the inclusion of intein elements reduced background activity of CRE-DOG, but one could speculate that the extra elements influenced the orientation or conformation of the split protein fragments such that non-specific CRE-DOG assembly was inhibited in the absence of GFP. Whether split intein elements would also aid in reducing background activity of other ligand-inducible split protein systems is an interesting issue to consider in the future.
From a broader perspective, our work demonstrates the utility of artificially derived-binding proteins (for example, nanobodies, intrabodies, etc.) for constructing split enzyme systems inducible by intracellular proteins. The ability to rapidly isolate additional highaffinity nanobodies should facilitate the extension of this approach to other target proteins 38 . Our work thus offers a new approach for engineering protein-inducible systems in addition to providing a practical solution for retrofitting GFP reporter lines for a much broader set of applications.
METhODS
Methods and any associated references are available in the online version of the paper.
Note: Any Supplementary Information and Source Data files are available in the online version of the paper. rAAV production and injections. rAAV (serotype 2/8 or 2/1) were made from pAAV-EF1a-N-CretrcintG, pAAV-EF1a-C-CreintG, pAAV-FLEX-tdT, pAAV-EF1a-GFP and pAAV-EF1a-ZsGreen. All rAAV, with the exception of rAAV-2/1-CAG-FLEX-ChR2-tdT (UPenn vector core, aliquot generously provided by B. Sabatini, Harvard Medical School) were generated by C. Wang of Z. He's laboratory (Boston Children's Hospital). All rAAV were injected in the range between 10 14 -10 15 genome copies per ml, assayed by PCR of rAAV vectors. Primer sequences are GACCTTTGGTCGCCCGGCCT and GAGTTGGCCACTCCCTCTCTGC, which target the ITR region of rAAV vectors.
For Supplementary Figure 9 , rAAV-2/8-EF1a-N-CretrcintG, rAAV-2/8-EF1a-C-CreintG and rAAV-2/8-FLEXtdT were co-injected with rAAV-2/8-EF1a-GFP or rAAV2/8-EF1a-ZsGreen into P0 mouse retina. Injected retinas were harvested in adulthood, between P21-30.
For Tg(TRHR-GFP) and Tg(CDH3-GFP) rAAV experiments, retinas were injected with rAAV-2/8 or rAAV-2/1 individually encoding N-CretrcintG, C-CreintG and FLEX-tdT into P4 or 2-3-month-old animals. 2-4 weeks postinfection, retina and brain sections were processed as described previously [45] [46] [47] . A brief description is provided in the histology section.
For rAAV infection of the spinal cord, P21 Tg(CBLN2-GFP) mice and GFPnegative littermates of either sex aged were anesthetized with a continuous level of 2% isoflurane (vol/vol). A total volume of 400 nl of the following viral constructs: rAAV2/1-EF1a-N-CretrcintG, rAAV2/1-EF1a-C-CreintG, rAAV2/1-FLEX-tdT was injected over four injection sites between vertebrae L3-L5. 4 weeks later, lumbar spinal cord tissue was collected for immunohistochemistry.
For rAAV infection of cerebellum and the cortex, Tg(GAD67-GFP) + mice and GFP-negative littermates of either sex aged 3-4 weeks were anesthetized with ketamine/xylazine/acepromazine at 100, 2.5 and 3 mg per kg of body weight, respectively, and a continuous level of deep anesthesia was maintained with 5% isoflurane. A total volume of 200 nl of the following viral constructs: rAAV-2/1-EF1a-N-CretrcintG, rAAV-2/1-EF1a-C-CreintG, rAAV-2/1-FLEX-tdT, or rAAV-2/1-CAGGS-FLEX-ChR2-tdT.WPRE.SV40 was injected into cerebellar lobule V or motor cortex using a stereotactic device. 3 weeks later, brain tissue was fixated for immunohistochemistry, or prepared for electrophysiology.
Histology. Retinal immunohistochemistry. Isolated mouse retinas were fixed at ~20-25 °C for 30 min in 4% paraformaldehyde (PFA, wt/vol)/phosphatebuffered solution (PBS). Retinas were then transferred to 30% sucrose (wt/vol) in PBS, and subsequently into a 50/50 mixture of 30% sucrose/PBS and OCT for sectioning. 20 µm retinal cryosections were cut on a Leica CM3050 cryostat (Leica Microsystems), using disposable blades. Retinal cryosections were incubated in blocking solution (5% normal donkey serum (vol/vol), 0.1% Triton-X (vol/vol) in PBS) for 1 h and stained with primary antibody overnight at 4 °C. Immunostained cryosections were washed three times in 0.1% Triton-X in PBS and stained for secondary antibodies in blocking solution for 2 h at ~20-25 °C. Slides were then washed in 0.1% Triton-X in PBS and mounted for imaging in Fluoromount-G (Southern Biotechnology Associates; 0100-01). Retinal sections were taken on a Zeiss LSM780 confocal microscope. Slides were scanned using a 40× or 63× oil immersion objective.
For rAAV infected transgenic GFP retinas, mice were transcardially perfused with 1xPBS followed by 4% PFA. Eyes were fixed in 4% PFA for 3-4 h and retinas dissected and rinsed in 1× PBS. Retinas were incubated for 2 h in blocking solution (10% goat serum (vol/vol), 0.25% Triton-X, 1× PBS) at ~20-25 °C followed by incubation with block solution containing primary antibodies at 4 °C overnight. Tissue was washed in 1× PBS (three times, 30 min). Retinas were incubated in block solution containing secondary antibody for 2 h at ~20-25 °C, and washed in PBS (three times, 30 min). Then, retinas were mounted and cover slipped with Vectashield containing DAPI (Vector Laboratories) and imaged using either an epifluorescent Zeiss Axio Imager 2 or a Zeiss LSM 780 confocal microscope 47 .
Spinal cord immunohistochemistry. Mice were transcardially perfused with 4% PFA in PBS (pH = 7.4) and the spinal cord was post-fixed overnight at 4 °C in the same solution. Sagittal slices of the lumbar spinal cord were cut at 50-µm thickness on a Leica VT1000S vibratome. Free-floating sections were immunostained using standard methods for spinal cord histology (for a detailed protocol, see ref. 48) . Stained slices were then mounted on Superfrost plus slides (VWR) with Fluoromount-G (SouthernBiotech). Images were acquired with an LSM700 confocal microscope.
Cerebellar immunohistochemistry. Mice were transcardially perfused with 4% PFA in PBS (pH = 7.4) and the brain was post-fixed overnight at 4 °C in the same solution. Parasagittal vermal slices of the cerebellum were cut at 40-µm thickness on a Leica VT1000S vibratome. Free-floating sections were immunostained using standard methods. Slices were then mounted on Superfrost slides (VWR) using Prolong Diamond mounting medium (Invitrogen). Images were acquired with an Olympus FV1000 or FV1200 confocal microscope. Whole brain sections were imaged on an Olympus MVX10 MacroView dissecting scope.
Antibodies and stains. For immunohistochemistry of retinas: rabbit anti-GFP (1:500 dilution, A-6455, Invitrogen), chicken anti-β-galactosidase (1:1,000 dilution, (ab9361, Abcam), rabbit anti-TagRFP (1:1,000, AB233, Evrogen). Note that anti-TagRFP also recognizes TagBFP and shows cross-reactivity to mCherry. The mCherry cross-reactivity did not cause problems for our analysis. In fact, it was advantageous in our identification of electroporated cells in the Tg(PROX1-GFP) experiment. Secondary antibodies raised against the relevant species were obtained from Jackson ImmunoResearch or Invitrogen.
For immunohistochemistry of rAAV-infected transgenic GFP retinas: rabbit anti-DsRed (1:2,000 dilution, 632292, Clontech), chicken anti-GFP (1:2,000 dilution, 1020, Aves Labs).
For spinal cord immunohistochemistry: chicken anti-GFP (1:1,000 dilution, 1020, Aves Labs), rabbit anti-DsRed (1:1,000 dilution, 632292, Clontech), rabbit anti-Cre (1:200 dilution, 69050-3, Novagen), Isolectin GS-IB4 (Alexa Fluor conjugated, Molecular Probes, 1:500).
For cerebellar and cortical immunohistochemistry: chicken anti-GFP (1:200 dilution, ab13970, Abcam), rabbit anti-calbindin (1:500 dilution, AB1779, Millipore), rabbit anti-parvalbumin (1:1,000 dilution, PV25, Swant), rabbit anti-Cre (1:200 dilution, 69050-3, Novagen). Secondary antibodies: goat anti-rabbit and chicken anti-rabbit coupled to Alexa 647 (1:1,000 A-21443 and A21245, Invitrogen).
Slice preparation for electrophysiology. Mice were anaesthetized with isoflurane and decapitated. The brain was quickly removed and immersed in oxygenated ice-cold cutting solution containing (in mM) 110 choline chloride, 25 glucose, 25 NaHCO 3 , 11.5 sodium ascorbate, 7 MgCl 2 , 3 sodium pyruvate, 2.5 KCl, 1.25 NaH 2 PO 4 , 0.5 CaCl 2 . Parasagittal cerebellar slices were cut at 270-µm thickness on a Leica VT1200S and subsequently allowed to recover for 30 min at 32 °C in artificial cerebrospinal fluid (ACSF) equilibrated with 95% O 2 and 5% CO 2 , containing (in mM) 125 NaCl, 26 NaHCO 3 , 1.25 NaH 2 PO 4 , 2.5 KCl, 1, MgCl 2 , 2 CaCl 2 , and 25 glucose. Slices were then kept at 21-23 °C for up to 5 h. electrophysiological recordings. Slices were superfused with 31-32 °C warm ACSF at a flow rate of ~3 ml min −1 in a recording chamber heated by an inline heater (Warner instruments). PCs and MLIs were visualized using an Olympus BX51WI microscope equipped with differential interference contrast (DIC). GFP + and ChR2-tdT + were imaged using a custom twophoton laser-scanning microscope with 750 nm illumination 49 . Visually guided recordings were performed with ~2 MΩ (PCs) and 3.5 MΩ (MLIs) borosilicate glass pipettes (Sutter Instrument). The internal solution for voltage-clamp recordings contained the following (in mM): 140 cesium methanesulfonate, 15 HEPES, 0.5 EGTA, 2 TEA-Cl, 2 MgATP, 0.3 NaGTP, 10 phosphocreatine-tris 2 , and 2 QX 314-Cl (pH adjusted to 7.2 with CsOH). For current-clamp recordings, the internal solution contained 150 potassium gluconate, 3 KCl, 10 HEPES, 0.5 EGTA, 3 MgATP, 0.5 GTP, 5 phosphocreatinetris 2 , and 5 sodium phosphocreatine (pH adjusted to 7.2 with KOH). Recordings were performed with a 700B Axoclamp amplifier (Molecular Devices) and were controlled with custom software written in Matlab (generously provided by B. Sabatini, Harvard Medical School). ChR2-tdT + cells were excited using a 473-nm wavelength blue laser (OptoEngine) coupled through the excitation pathway of the microscope. Laser light was focused onto slices through a 40× water-immersion objective. Brief light pulses (0.5-1 ms) at an intensity of 3-5 mW mm −2 evoked ChR2-mediated photocurrent and stimulus-locked action potentials.
data analysis. Imaging data was analyzed and processed with ImageJ (US National Institutes of Health), Imaris (Bitplane), ZEN (Carl Zeiss Microscopy) npg and/or Photoshop (Adobe Systems) software. Prism (GraphPad) was used to generate graphs. Electrophysiological data was analyzed with IgorPro (Wavemetrics), AxographX (Axograph Scientific) and Prism (GraphPad). For luciferase assays, two-tailed Student's t test assuming unequal variance was used for all comparisons. P < 0.05 is judged as statistically significant. For cerebellar data, statistical significance was assessed with two-tailed Student's t-test ( Fig. 7i) assuming unequal variance or one-way ANOVA (Fig. 7h) . Statistical significance was assumed when P < 0.05.
Quantifications. Quantification of cells was performed on the imaging software ZEN (Zeiss) or ImageJ (US National Institutes of Health). The ImageJ plugin, Cell Counter, was used to aid counting.
Quantification of electroporated retinas. Confocal Z-stack images were taken of retinal regions with dense expression of electroporation markers. Electroporated cells were marked by the presence of electroporated GFP, n-βgal (from CAG-nlacZ) or the combination of TagBFP and mCherry (driven from ChAG-loxP-tBFPL-loxP-mCherry cassette; combination is detected by a polyclonal TagRFP antibody that detects both TagBFP and mCherry). Cells expressing a given marker (for example, Y) were selected using ImageJ Cell Counter plug-in, and then evaluated for coexpression of a second marker of interest (for example, X). Counted number of the second marker were divided by selected number of cells expressing the given marker, and multiplied by 100 to get the percentage of X + cell given Y + cell (for example, % X + /Y + ). This general quantification scheme was also used for rAAV-infected tissues. To avoid counting green fluorescent DsRed molecules in GFP and DsRed colocalization analysis, we imaged for Anti-GFP expression in the blue or far red channel, and occasionally used the native GFP fluorescence as an aid for determining GFP expression.
Electroporated retina cells labeled by either n-βgal or TagBFP immunostaining were quantified for DsRed or mCherry fluorescence, respectively. Using ImageJ, a mask for the chosen cell body was created on the anti-βgal or anti-TagBFP channels and transferred to the DsRed or mCherry fluorescence channel, respectively. Measurements of the mean pixel intensity on single confocal slices were taken for the chosen cell bodies. Each measurement was paired with a background fluorescence intensity measurement from the same slice, chosen at a location in the slice where no cells were present. Each measurement was then subtracted from the background to obtain the net fluorescence, in arbitrary units (a.u.). We found mCherry to show slight aggregation in retinal cells, especially INL cell types. Thus, we avoided quantifying cellular regions with strong mCherry aggregation. To quantify fluorescence, we drew a shape circling the soma region with minimal aggregation in the confocal slice corresponding to the strongest mCherry fluorescence.
Quantification of rAAV-infected tissues.
Confocal Z-stack images of rAAVinfected retinal, spinal cord, or brain samples were manually analyzed on ZEN or ImageJ for marker expression. For GFP-positive retinas, entire retinas were analyzed for tdT expression. For GFP-negative samples, tissue areas showing Cre-immunostaining were imaged and analyzed for tdT expression amongst Cre-immunopositive cells.
To estimate the rough efficiency of labeling in brain infections, GFP + cells in densely infected areas were counted, and the number of overlapping tdT + cells was determined. The GFP-overlapping tdT + cell count was divided by the number of counted GFP + cells, and multiplied by 100 to obtain the % tdT + /GFP + parameter. For cerebellum, this analysis was performed in slices immunostained against GFP to enhance GFP brightness. To refine the efficiency measure in infected spinal cords and brains, we counted GFP cells that were immunostained with polyclonal Cre antibody, and determined the number of tdT + cells overlapping with this GFP + ,Cre + cell population. The number of tdT + cells overlapping with GFP + , Cre + cells were divided by the total number of counted GFP + , Cre + cells, and multiplied by 100 to obtain the % tdT + /GFP + , Cre + parameter. The efficiency in MLIs could not be quantified in this manner because the dense anti-Cre-staining of PC dendrites obscured MLIs in the cerebellar molecular layer.
To estimate leak expression of tdT + in GFP-negative animals, all or randomly selected cells immunopositive for Cre were counted, and then the number of overlapping tdT + cells was determined. This measure provides an estimate of the percentage of Cre-expressing cells showing background CRE-DOG activity. The same calculation in GFP + animals allows an estimate of induction.
Additional quantifications.
To determine GFP specificity CRE-DOG in electroporated and rAAV infected tissues, cells expressing the Cre-dependent reporter (tdT, DsRed or mCherry) were either randomly counted or counted in their entirety within an image. The number of overlapping GFP + cells was then determined. This value was divided by the number of counted tdT + , DsRed + or mCherry + cells, and then multiplied by 100 to obtain the % GFP + /tdT, GFP + / DsRed + or GFP + /mCherry + parameter.
A Supplementary methods checklist is available.
